Bio-Rad Laboratories Class B
BIO.B
8 hedge funds and large institutions have $2.22M invested in Bio-Rad Laboratories Class B in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.01% less ownership
Funds ownership: 0.11% → 0.1% (-0.01%)
19% less capital invested
Capital invested by funds: $2.75M → $2.22M (-$531K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WT
Whittier Trust
South Pasadena,
California
|
+$77.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$486 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$200K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$60K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $879K | – | – | – |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $603K | – | – | – |
|
|
BSW
3
Buckingham Strategic Wealth
Clayton,
Missouri
| $317K | – | – | – |
|
4
Morgan Stanley
New York
| $302K | – | – | – |
|
|
WT
5
Whittier Trust
South Pasadena,
California
| $73K | +$77.8K | +160 | New |
|
6
Wells Fargo
San Francisco,
California
| $23K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $21K | – | – | – |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$200K | -405 | Closed |
|
|
9
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$60K | -122 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | +$486 | +1 | New |
|
BIO.B Hedge Fund Activity: Q3 2022 in Review
8 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2022, worth a combined $2.22M — down 19% from $2.75M a quarter earlier.
Fund positioning in BIO.B was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Whittier Trust, opening a new position worth an estimated $77.8K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $200K sold.
- 8 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $2.22M of Bio-Rad Laboratories Class B stock for Q3 2022, down 19% quarter-over-quarter.
- 2 funds opened new Bio-Rad Laboratories Class B positions in Q3 2022 and 2 closed out, a net change of 0 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q3 2022 was Whittier Trust, an estimated $77.8K added.
- The largest Bio-Rad Laboratories Class B seller in Q3 2022 was Susquehanna International Group, an estimated $200K sold.
Based on aggregated 13F filings for Q3 2022.